ESMO 2023 | Professor Ning Liao: The Extension of the T-DXd Anti-HER2 Landscape in DESTINY-PanTumor01
Editor's Note: Anti-HER2 therapy has traditionally been implemented based on HER2 expression detected through immunohistochemistry. In clinical practice, a small subset of patients with HER2-negative expression may have HER2 gene…